Use of GLP-1 receptor agonists is associated with a lower risk of death than use of DPP4 inhibitors in older patients with cancer and type 2 diabetes, data suggest.

Critics of most-favored-nation drug pricing have warned that it could reduce patient access to certain drugs, raise the prices of other drugs, and decrease research and development for new drugs.

(HealthDay News) — After months with an appointed caretaker, the US Centers for Disease Control and Prevention (CDC) now has an official director. Dr Susan Monarez, who became the agency’s acting ...

If confirmed, our findings may provide a more precise clinical target for definitive trials of PA as a prostate cancer treatment as well as for PA promotion efforts in newly diagnosed prostate cancer ...

This study underscores the need for future prospective studies and interventions to address current and impending drug shortages among practices, and a thorough policy approach is necessary to address ...

Out-of-pocket costs are higher for cancer patients who have a higher stage of disease at diagnosis, data suggest.

Our findings do not suggest high utilization of neoadjuvant chemotherapy is associated with a trade-off between perioperative and long-term outcomes,” the researchers wrote.

Health care providers can take steps to protect patients targeted by ICE, ensuring that patients retain their privacy and access to care.

Lifesaving research projects on cancer, vaccine hesitancy, and health equity are being denied funding for political reasons,” the report notes.

Hospital officials are warning that changes in President Donald Trump’s budget and tax bill put them on an unsustainable track that could lead to closures or loss of services in rural communities.

Some GOP lawmakers in Congress have heralded the $50 billion rural program as a health care victory. But it’s still unclear which hospitals, clinics, and other providers would receive money and how ...

Systematic mediastinal lymph node dissection (LND) is “unnecessary” for patients with ground glass opacity (GGO)-dominant invasive lung adenocarcinoma and low risk of nodal involvement, according to ...